Should You Put Off Joint Surgery During COVID-19?

October 24, 2020 Business, COVID-19, Health, Joint Replacement, Medical Devices, Zimmer Biomet

Zimmer Biomet launched an educational campaign in an effort to encourage people with chronic joint pain to make informed decisions about joint surgery during COVID-19.

Orthopedic companies are anxious to get patients back into the operating room for hip and knee replacements. Zimmer Biomet recently launched an educational campaign in an effort to guide people with chronic joint pain on navigating joint surgery during COVID-19.

The company said that the multimedia campaign, Don’t Let Pain Gain on You, is informed by the results of a new U.S. survey that reveals nearly half (48%) of joint surgery candidates have postponed treatment due to fears stemming from the COVID-19 pandemic.

“We understand why the pandemic has created uncertainty around elective procedures like joint replacement surgery, but we also know that for some people coping with chronic debilitating joint pain, postponing a necessary procedure could have a significant impact on quality of life and continue to cause life-altering pain and loss of mobility,” said Ivan Tornos, group president for global businesses and the Americas at Zimmer Biomet. “With this new campaign, we look to encourage people to have a proactive conversation with their doctor about joint replacement surgery and get the support and care they need to address their pain, safely and with confidence.”

The U.S. survey of 1,200 joint surgery patients, candidates, and caregivers, conducted in August and September 2020 by Wakefield Research on behalf of Zimmer Biomet, revealed that the vast majority (82%) of people who did undergo joint surgery during the pandemic said that they felt safe doing so, and 64% said they did not feel at risk for contracting a virus, such as COVID-19, at the site of their surgery.

By Amanda Pedersen | MD+DI

Image Credit: The New York Times

READ MORE

About Peter Coffaro 510 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.